Practical, stereoselective synthesis of palinavir, a potent HIV protease inhibitor

Journal of Organic Chemistry

Volumn 62, Issue 11, 1997, Pages 3440-3448

  Beaulieu, Pierre L ^a   Lavallée, Pierre ^a   Abraham, Abraham ^a   Anderson, Paul C ^a   Boucher, Colette ^a   Bousquet, Yves ^a   Duceppe, Jean Simon ^a   Gillard, James ^a   Gorys, Vida ^a   Grand Maître, Chantal ^a   Grenier, Louis ^a,b   Guindon, Yvan ^a   Guse, Ingrid ^a   Plamondon, Louis ^a,b   Soucy, François ^a,b   Valois, Serge ^a   Wernic, Dominik ^a   Yoakim, Christiane ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^b ProScript Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PALINAVIR; PROTEINASE INHIBITOR;

ARTICLE; DRUG PURITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

EID: 8544222655     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9702655     Document Type: Article

References (60)

1. (a) Barre-Sinoussi, F.; Chermann, J.-C.; Rey, F.; Nugeyre, M. T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Brun-Vezinet, F.; Rouzioux, C.; Rozenbaum, W.; Montagnier, L. Science 1983, 220, 868.
2. (b) Gallo, R. C.; Salahuddin, S. Z.; Popovic, M.; Shearer, G. M.; Kaplan, M.; Haynes, B. F.; Palker, T. J.; Redfield, R.; Oleske, J.; Safai, B.; White, G.; Foster, P.; Markham, P. D. Science 1984, 224, 500.
3. Darke, P. A.; Huff, J. R. Adv. Pharmacol. 1994, 25, 399-454.
4. (a) Khol, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A. F.; Scolnick, E. M.; Sigal, I. S. Proc. Natl. Acad. Sci. U.SA. 1988, 85, 4686-4690.
5. (b) Kramer, R. A.; et al. Science 1986, 237, 1580-1584.
6. (a) De Clercq, E. J. Med. Chem. 1995, 38, 2491-2517.
7. (b) Boehme, R. E.; Borthwick, A. D.; Wyatt, P. G. Ann. Rep. Med. Chem. 1995, 30, 139-149.
8. (c) Thaisrivongs, S. Annu. Rep. Med. Chem. 1994, 29, 133-144.
9. (d) Huff, J. R. J. Med. Chem. 1991, 34, 2305-2314.
10. (a) Pillay, D.; Bryant, M.; Getman, D.; Richman, D. D. Rev. Med. Virol. 1995, 5, 23.
11. (b) Cohen, J. Science 1996, 272, 1880.
12. (c) Cohen, J. Science 1996, 272, 1882.
13. Kempf, D. J.; Sham, H. L. Curr. Pharmaceut. Des. 1996, 2, 225-246.
14. (a) Vara Prasad, J. V. N.; Para, K. S.; Lunney, E. A.; Ortwine, D. F.; Dunbar, J. B., Jr.; Ferguson, D.; Tummino, P. J.; Hupe, D.; Tait, B. D.; Domagala, J. M.; Humblet, C.; Bhat, T. N.; Liu, B.; Guerin, D. M. A.; Baldwin, E. T.; Erickson, J. W.; Sawyer, T. K. J. Am. Chem. Soc. 1994, 116, 6989.
15. (b) Lunney, E. A.; Hagen, S. E.; Domagala, J. M.; Humblet, C.; Kosinski, J.; Tait, B. D.; Warmus, J. S.; Wilson, M.; Ferguson, D.; Hupe, D.; Tummino, P. J.; Baldwin, E. T.; Bhat, T. N.; Liu, B.; Erickson, J. W. J. Med. Chem. 1994, 37, 2664.
16. (c) Thaisrivongs, S.; Tomich, P. K.; Watenpaugh, K. D.; Chong, K.-T.; Strohback, J. W.; Turner, S. R.; McGrath, J. P.; Bohanon, M. J.; Lynn, J. C.; Mulichak, A. M.; Spinelli, P. A.; Hinshaw, R. R.; Pagano, P. J.; Moon, J. B.; Ruwart, M. J.; Wilkinson, K. F.; Rush, B. D.; Zipp, G. L.; Dalga, R. J.; Schwende, F. J.; Howard, G. M.; Padbury, G. E.; Toth, L. N.; Zhao, Z.; Koeplinger, K. A.; Kakuk, T. J.; Cole, S. L.; Zaya, R. M.; Piper, R. C.; Jeffrey, P. J. Med. Chem. 1994, 37, 3200.
17. (d) Melnick, M.; Reich, S. H.; Lewis, K. K.; Mitchell, L. J., Jr.; Nguyen, D.; Trippe, A. J.; Dawson, H.; Davies, J. F., II; Appelt, K.; Wu, B.-W.; Musick, L.; Gehlhaar, D. K.; Webber, S.; Shetty, B.; Kosa, M.; Kahil, D.; Andrada, D. J. Med. Chem. 1996, 39, 2795.
18. Zurer, P. Chem. Eng. News 1996, 74 (1), 6.
19. (a) Anderson, P. C.; Soucy, F.; Yoakim, C.; Lavallée, P.; Beaulieu, P. L. U.S. Patent 5 614 533, 1997.
20. (b) Gorys, V.; Soucy, F.; Yoakim, C.; Beaulieu, P. L. U.S. Patent 5 552 405, 1996.
21. (c) Beaulieu, P. L.; Guse, I. U.S. Patent 5 545 640, 1996.
22. (d) Beaulieu, P. L.; Wernic, D.; Abraham, A.; Anderson, P. C.; Bogri, T.; Bousquet, Y.; Croteau, G.; Guse, I.; Lamarre, D.; Liard, F.; Paris, W.; Thibeault, D.; Pav, S.; Tong, L. J. Med. Chem. 1997, in press.
23. Lamarre, D.; Croteau, G.; Bourgon, L.; Thibeault, D.; Wardrop, E.; Clouette, C.; Vaillancourt, M.; Cohen, E.; Pargellis, C.; Yoakim, C.; Anderson, P. C. Antimicrob. Agents Chemother. 1997, 41, in press.
24. Unpublished results.
25. Tong, L.; Pav, S.; Mui, S.; Lamarre, D.; Yoakim, C.; Beaulieu, P.; Anderson, P. C. Structure 1995, 3, 33-40.
26. Barrish, J. C.; Gordon, E.; Alam, M.; Lin, P.-F.; Bisacchi, G. S.; Chen, P.; Cheng, P. T. W.; Fritz, A. W.; Greytok, J. A.; Hermsmeier, M. A.; Humphreys, W. G.; Lis, K. A..; Marella, M. A.; Merchant, Z.; Mitt, M.; Morrison, R. A.; Obermeier, M. T.; Pluscec, J.; Skoog, M.; Slusarchyk, W. A.; Spergel, S. H.; Stevenson, J. M.; Sun, C.-q.; Sundeen, J. E.; Taunk, P.; Tino, J. A.; Warrack, B. M.; Colonno, R. J.; Zahler, R. J. Med. Chem. 1994, 37, 1758-1768. The procedure described in this paper for the preparation of 3 requires the use of diazomethane and consequently cannot be used for preparing large quantities of this key intermediate.
27. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 14, 1219.
28. (a) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merrett, J. K.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656 and references cited therein.
29. (b) Shum, W. P.; Chen, J.; Cannarsa, M. J. Chirality 1994, 6, 681 and references cited therein.
30. (c) Gurjar, M. K.; Devi, N. R. Tetrahedron Asymm. 1994, 5, 755.
31. (d) Albeck, A.; Persky, R. Tetrahedron 1994, 50, 6333.
32. (e) Pégorier, L.; Petit, Y.; Larchevêque, M. J. Chem. Soc. Chem. Commun. 1994, 633.
33. (f) Castejón, P.; Pastó, M.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1995, 36, 3019.
34. (g) Green, B. E.; Chen, X.; Norbeck, D. W.; Kempf, D. J. Synlett. 1995, 613.
35. (h) Rotella, D. P. Tetrahedron Lett. 1995, 36, 5453.
36. (i) Heinsoo, A.; Raidaru, G.; Linask, K.; Järv, J.; Zetterström, M.; Langel, Ü. Tetrahedron Asymm. 1995, 6, 2245.
37. (j) Dondoni, A.; Perrone, D.; Merino, P. J. Org., Chem. 1995, 60, 8074
38. (a) Beaulieu, P. L.; Wernic, D.; Duceppe, J.-S.; Guindon, Y. Tetrahedron Lett. 1995, 36, 3317.
39. (b) Beaulieu, P. L.; Wernic, D. J. Org. Chem. 1996, 61, 3635.
40. (c) Barluenga, J.; Baragaña, B.; Alonso, A.; Concellón, J. M. J. Chem. Soc., Chem. Commun. 1994, 969.
41. (d) Barluenga, J.; Baragana, B.; Concellón, J. M. J. Org. Chem. 1995, 60, 6696.
42. (e) NG, J. S.; Przybyla, C. A.; Liu, C.; Yen, J. C.; Muellner, F. W.; Weyker, C. L. Tetrahedron 1995, 51, 6397.
43. N,N-Dibenzyl-L-phenylalaninol (11) is commercially available from the Nutrasweet Company.
44. See references cited in: (a) Gillard, J.; Abraham, A.; Anderson, P. C.; Beaulieu, P. L.; Bogri, T.; Bousquet, Y.; Grenier, L.; Guse, I.; Lavallée, P. J. Org. Chem. 1996, 61, 2226-2231. (b) Skiles, J. W.; Giannousis, P. P.; Fales, K. R. Bioorg. Med. Chem. Lett. 1996, 6, 963-966.
45. See references cited in: (a) Gillard, J.; Abraham, A.; Anderson, P. C.; Beaulieu, P. L.; Bogri, T.; Bousquet, Y.; Grenier, L.; Guse, I.; Lavallée, P. J. Org. Chem. 1996, 61, 2226-2231. (b) Skiles, J. W.; Giannousis, P. P.; Fales, K. R. Bioorg. Med. Chem. Lett. 1996, 6, 963-966.
46. Hays, S. J.; Malone, T. C.; Johnson, G. J. Org. Chem. 1991, 56, 4084.
47. (a) Bassett, H. L.; Thomas, C. R. J. Chem. Soc. 1954, 1188-1190.
48. (b) Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-H.; Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461-5464. On a large scale, the amination of lactones and esters using the less reactive magnesium amides is less hazardous and less costly then the corresponding aluminum reagents.
49. This is not a true resolution process per se, since hydroxy amides 18a,b are diastereomeric in nature.
50. Davis, J. W., Jr. J. Org. Chem. 1959, 24, 1691-1694. The acid chloride crystallized as pale yellow needles in 82% yield: mp 94-96 °C dec [lit. mp 96-97 °C].
51. (a) Posner, G. H.; Rogers, D. Z. J. Am. Chem. Soc. 1977, 99, 8208-8214.
52. (b) Bennett, F.; Patel, N. M.; Girijavailabhan, V. M.; Ganguly, A. K. Synlett 1993, 703-704.
53. (c) Chini, M.; Crotti, P.; Favero, L.; Macchia, F.; Pineschi, M. Tetrahedron Lett. 1994, 35, 433-436 and references cited therein.
54. Kemp, D. S. The Peptides; Gross, E.; Meienhofer, J., Eds.; Academic Press Inc.: New York, 1979; Vol. 1, p 315.
55. Knorr, R.; Trzeciak, A.; Bannwarth, W.; Gillessen, D. Tetrahedron Lett. 1989, 30, 1927-1930.
56. (a) Bodanszky, M. In Principles of Peptide Synthesis; Springler-Verlag: New York, 1984.
57. (b) The Peptides; Gross, E., Meienhofer, J., Eds.; Academic Press, Inc.: New York, 1979; Vol. 1.
58. The authors have deposited atomic coordinates for this structure with the Cambridge Crystallographic Data Center. The coordinates can be obtained, on request, from the Director, Cambridge Crystallographic Data Center, 12 Union Road, Cambridge CB2 1EZ, U.K.
59. The order and rate of addition, the use of dilute solutions, and efficient stirring are important, to avoid precipitation of the monohy- drochloride salt of 1.
60. The free base of 4-picoylyl chloride is unstable and polymerizes if the etheral solution is concentrated to dryness. Addition of DMF before removal of ether ensures the free base remains as a dilute solution, thus reducing the extent of self-condensation. The polymerization process is also minimized if the solutions are kept cold.